{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:46:10Z","timestamp":1792118770970,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijantimicag.2025.107482","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T12:05:23Z","timestamp":1740657923000},"page":"107482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Posaconazole effectiveness in rare invasive fungal infections: A systematic literature review"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4894-6650","authenticated-orcid":false,"given":"Mark","family":"Bernauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty","family":"Waskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cossrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allysen","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havilland","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107482_bib0001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Queiroz-Telles","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/2040620716656381","article-title":"Recent developments in the management of invasive fungal infections in patients with oncohematological diseases","volume":"7","author":"Ruhnke","year":"2016","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0004","unstructured":"Centers for Disease Control and Prevention. \"Information for healthcare professionals about mucormycosis.\" https:\/\/www.cdc.gov\/fungal\/diseases\/mucormycosis\/health-professionals.html (accessed July 20, 2020)."},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1473-3099(15)00359-X","article-title":"Mycetoma: a unique neglected tropical disease","volume":"16","author":"Zijlstra","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/jof2010002","article-title":"Phaeohyphomycosis in transplant patients","volume":"2","author":"Revankar","year":"2015","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0007","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.trstmh.2012.07.003","article-title":"Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan","volume":"106","author":"Zein","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0016","unstructured":"\"Noxafil. Prescribing information. Merck.\" https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/205053s011,205596s013lbl.pdf (accessed May 8, 2021)."},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0017","unstructured":"European Medicines Agency. \"Noxafil: EPAR\u2014product information.\" https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/noxafil-epar-product-information_en.pdf (accessed July 10, 2020)."},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0018","first-page":"410","article-title":"Clinical practice update of antifungal prophylaxis in immunocompromised children","volume":"32","author":"Ramos","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0019","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0020","unstructured":"National Institute for Health and Care Excellence. \"Single technology appraisal and highly specialised technologies evaluation: user guide for company evidence submission template.\" http:\/\/www.nice.org.uk\/article\/pmg24\/chapter\/Instructions-for-companies. (accessed September 18, 2019)."},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0021","unstructured":"Centre for Reviews and Dissemination. \"Systematic reviews. CRD's guidance for undertaking reviews in health care.\" http:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf. (accessed April 2, 2018)."},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007019","article-title":"The disabling consequences of mycetoma","volume":"12","author":"Abbas","year":"2018","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003679","article-title":"Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan","volume":"9","author":"Fahal","year":"2015","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0013","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1590\/abd1806-4841.20187321","article-title":"Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update","volume":"93","author":"Brito","year":"2018","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0014","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2217\/fmb.13.78","article-title":"Epidemiology and treatment of mucormycosis","volume":"8","author":"Lewis","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0022","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0023","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0024","doi-asserted-by":"crossref","first-page":"ofad704","DOI":"10.1093\/ofid\/ofad704","article-title":"A systematic review of the therapeutic outcome of mucormycosis","volume":"11","author":"Sigera","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0026","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0027","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0028","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107482_bib0029","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:40:39Z","timestamp":1762321239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0924857925000391"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107482","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posaconazole effectiveness in rare invasive fungal infections: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. and The Author(s). Published by Elsevier Ltd. and International Society of Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}],"article-number":"107482"}}